Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000950170-24-046916

Options or other derivatives

  • Director bought 9,677,419 shares at $7.13 ($68,999,030)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BAKER BROS. ADVISORS LP Director 2024-04-19 Purchase · Warrants to purchase Common Stock +825,968 $7.13 $5,889,069 4,018,678 I
BAKER BROS. ADVISORS LP Director 2024-04-19 Purchase · Warrants to purchase Common Stock +8,851,451 $7.13 $63,109,960 43,158,741 I
Loading xslF345X05/ownership.xml…